12-102958382-A-T

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_004316.4(ASCL1):​c.138A>T​(p.Ala46Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0062 in 1,470,852 control chromosomes in the GnomAD database, including 40 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0045 ( 3 hom., cov: 33)
Exomes 𝑓: 0.0064 ( 37 hom. )

Consequence

ASCL1
NM_004316.4 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -2.34

Publications

2 publications found
Variant links:
Genes affected
ASCL1 (HGNC:738): (achaete-scute family bHLH transcription factor 1) This gene encodes a member of the basic helix-loop-helix (BHLH) family of transcription factors. The protein activates transcription by binding to the E box (5'-CANNTG-3'). Dimerization with other BHLH proteins is required for efficient DNA binding. This protein plays a role in the neuronal commitment and differentiation and in the generation of olfactory and autonomic neurons. Mutations in this gene may contribute to the congenital central hypoventilation syndrome (CCHS) phenotype in rare cases. [provided by RefSeq, Jul 2008]
PAH (HGNC:8582): (phenylalanine hydroxylase) This gene encodes a member of the biopterin-dependent aromatic amino acid hydroxylase protein family. The encoded phenylalanine hydroxylase enzyme hydroxylates phenylalanine to tyrosine and is the rate-limiting step in phenylalanine catabolism. Deficiency of this enzyme activity results in the autosomal recessive disorder phenylketonuria. [provided by RefSeq, Aug 2017]
PAH Gene-Disease associations (from GenCC):
  • phenylketonuria
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Myriad Women’s Health
  • classic phenylketonuria
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • maternal phenylketonuria
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • mild hyperphenylalaninemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • mild phenylketonuria
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 12-102958382-A-T is Benign according to our data. Variant chr12-102958382-A-T is described in ClinVar as Likely_benign. ClinVar VariationId is 227178.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.34 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 3 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ASCL1NM_004316.4 linkc.138A>T p.Ala46Ala synonymous_variant Exon 1 of 2 ENST00000266744.4 NP_004307.2 P50553
PAHNM_001354304.2 linkc.-283T>A 5_prime_UTR_variant Exon 1 of 14 NP_001341233.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ASCL1ENST00000266744.4 linkc.138A>T p.Ala46Ala synonymous_variant Exon 1 of 2 1 NM_004316.4 ENSP00000266744.3 P50553
PAHENST00000547319.1 linkn.29T>A non_coding_transcript_exon_variant Exon 1 of 3 4
PAHENST00000551337.5 linkc.-283T>A upstream_gene_variant 3 ENSP00000447620.1 F8W0A0
PAHENST00000635500.1 linkn.-160T>A upstream_gene_variant 3

Frequencies

GnomAD3 genomes
AF:
0.00455
AC:
674
AN:
148132
Hom.:
3
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00138
Gnomad AMI
AF:
0.0111
Gnomad AMR
AF:
0.00887
Gnomad ASJ
AF:
0.00116
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000425
Gnomad FIN
AF:
0.00446
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00618
Gnomad OTH
AF:
0.00439
GnomAD2 exomes
AF:
0.00475
AC:
399
AN:
84078
AF XY:
0.00431
show subpopulations
Gnomad AFR exome
AF:
0.00335
Gnomad AMR exome
AF:
0.00628
Gnomad ASJ exome
AF:
0.00131
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00313
Gnomad NFE exome
AF:
0.00768
Gnomad OTH exome
AF:
0.00374
GnomAD4 exome
AF:
0.00638
AC:
8441
AN:
1322612
Hom.:
37
Cov.:
29
AF XY:
0.00614
AC XY:
4001
AN XY:
652032
show subpopulations
African (AFR)
AF:
0.000598
AC:
15
AN:
25104
American (AMR)
AF:
0.00643
AC:
171
AN:
26608
Ashkenazi Jewish (ASJ)
AF:
0.00137
AC:
31
AN:
22646
East Asian (EAS)
AF:
0.00
AC:
0
AN:
28948
South Asian (SAS)
AF:
0.00121
AC:
86
AN:
71204
European-Finnish (FIN)
AF:
0.00282
AC:
121
AN:
42856
Middle Eastern (MID)
AF:
0.00171
AC:
7
AN:
4088
European-Non Finnish (NFE)
AF:
0.00738
AC:
7719
AN:
1046530
Other (OTH)
AF:
0.00533
AC:
291
AN:
54628
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
536
1073
1609
2146
2682
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
298
596
894
1192
1490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00455
AC:
674
AN:
148240
Hom.:
3
Cov.:
33
AF XY:
0.00439
AC XY:
318
AN XY:
72480
show subpopulations
African (AFR)
AF:
0.00137
AC:
54
AN:
39286
American (AMR)
AF:
0.00886
AC:
133
AN:
15018
Ashkenazi Jewish (ASJ)
AF:
0.00116
AC:
4
AN:
3436
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4950
South Asian (SAS)
AF:
0.000426
AC:
2
AN:
4696
European-Finnish (FIN)
AF:
0.00446
AC:
46
AN:
10314
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00618
AC:
416
AN:
67272
Other (OTH)
AF:
0.00434
AC:
9
AN:
2072
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
33
65
98
130
163
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00459
Hom.:
2
Bravo
AF:
0.00505

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Dec 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ASCL1: BP4, BP7, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Sep 02, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Ala46Ala in exon 1 of ASCL1: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. It has been identified in 0.2% (5/2136) of Eu ropean chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadi nstitute.org; dbSNP rs552552603). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
3.9
DANN
Benign
0.59
PhyloP100
-2.3
PromoterAI
0.25
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs552552603; hg19: chr12-103352160; API